
Search, filter, and sort every SKU. All batches HPLC & Mass Spec verified.
All peptides and compounds sold by Altitude Elite Labs are for research purposes only. By purchasing, you agree that you are a licensed researcher or qualified professional and are using these products solely for in-vitro research. Not for human or veterinary consumption, diagnosis, or treatment.





BPC-157 — pentadecapeptide fragment of body protection compound. Widely referenced in tissue repair, angiogenesis, and gut-lining research models. Lyophilized, ≥99% HPLC.

CJC-1295 No DAC (Mod GRF 1-29) — short-acting GHRH analog. Studied for pulsatile stimulation of the somatotroph axis. Lyophilized, ≥99% HPLC.

CJC-1295 (No DAC) + Ipamorelin blend — GHRH analog paired with a selective GHRP. Common reference stack in growth-hormone secretagogue research. Lyophilized, ≥99% HPLC.

GHK-Cu — copper tripeptide-1. Extensively studied for collagen synthesis, dermal remodeling, and antioxidant signaling. Lyophilized, ≥99% HPLC.

GHRP-2 — synthetic hexapeptide GH secretagogue. Referenced for robust GH pulses in endocrine research. Lyophilized, ≥99% HPLC.

GHRP-6 — growth-hormone releasing hexapeptide. Studied for GH secretion and ghrelin-receptor-mediated appetite signaling. Lyophilized, ≥99% HPLC.

GLOW-70 Blend — GHK-Cu, BPC-157, and TB-500 co-lyophilized. Reference stack for skin, hair, and connective-tissue research. ≥99% HPLC.


Ipamorelin — selective GHRP / ghrelin receptor agonist. Studied for pulsatile GH release with minimal effect on cortisol or prolactin. Lyophilized, ≥99% HPLC.

KLOW80 Blend — GHK-Cu, KPV, BPC-157, and TB-500 co-lyophilized. Reference stack for regenerative and anti-inflammatory research endpoints. ≥99% HPLC.



MK-677 (Ibutamoren) — orally active, non-peptide ghrelin receptor agonist. Studied for sustained IGF-1 elevation in growth-hormone axis research. Lyophilized powder, ≥99% HPLC.

Synthetic melanocortin peptide supplied for controlled in-vitro laboratory research and analytical study.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Retatrutide (LY3437943) — investigational triple agonist of GLP-1, GIP, and glucagon receptors. Studied for metabolic regulation, adipose reduction, and glycemic control. Lyophilized powder, ≥99% HPLC.

Selank — synthetic heptapeptide analog of tuftsin. Studied for anxiolytic and immunomodulatory activity in neuropeptide research. Lyophilized, ≥99% HPLC.

Semaglutide — long-acting GLP-1 receptor agonist. Referenced in research on glycemic regulation, satiety signaling, and cardiometabolic markers. Lyophilized powder, ≥99% HPLC.

Semaglutide — long-acting GLP-1 receptor agonist. Referenced in research on glycemic regulation, satiety signaling, and cardiometabolic markers. Lyophilized powder, ≥99% HPLC.

Semax — synthetic ACTH(4-10) analog. Referenced in nootropic, neuroprotective, and BDNF-signaling research. Lyophilized, ≥99% HPLC.



TB-500 — synthetic fragment of Thymosin Beta-4. Studied for actin regulation, cell migration, and connective-tissue repair endpoints. Lyophilized, ≥99% HPLC.

Tesamorelin — synthetic GHRH analog. Investigated for endogenous growth-hormone axis modulation and visceral adipose research endpoints. Lyophilized, ≥99% HPLC.


Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.

Tirzepatide — dual GIP / GLP-1 receptor agonist. Extensively studied for glucose homeostasis, appetite signaling, and body-composition endpoints in metabolic research models. Lyophilized, ≥99% HPLC.


Wolverine Blend — BPC-157 10mg + TB-500 10mg co-lyophilized. Reference stack for combined tissue-repair and angiogenesis research. ≥99% HPLC each.